Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial Academic Article uri icon

Overview

MeSH Major

  • Carrier Proteins
  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Membrane Transport Proteins
  • Osteosarcoma
  • RNA, Messenger
  • Tetrahydrofolate Dehydrogenase
  • Thymidylate Synthase
  • Transcription Factors

abstract

  • Daiichi Sankyo.

publication date

  • August 10, 2019

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(19)30764-0

PubMed ID

  • 31229240

Additional Document Info

start page

  • 478

end page

  • 487

volume

  • 394

number

  • 10197